N-terminal tyrosine phosphorylation of caveolin-2 negates anti-proliferative effect of transforming growth factor

Britain Abel1, Cara Willoughby, Sungchan Jang

  • 1Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA.

FEBS Letters
|July 24, 2012
PubMed

Insights

Tyrosine phosphorylation of caveolin-2 (Cav-2) counteracts the anti-proliferative effects of transforming growth factor beta (TGF-beta) in endothelial cells. This finding reveals a novel regulatory mechanism for TGF-beta signaling.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor beta (TGF-beta) signaling is crucial for regulating endothelial cell proliferation.
  • Caveolin-2 (Cav-2) is a protein involved in various cellular processes, including signal transduction.
  • The role of Cav-2 phosphorylation in TGF-beta signaling remains incompletely understood.

Purpose of the Study:

  • To investigate the role of caveolin-2 (Cav-2) phosphorylation in regulating the anti-proliferative function of transforming growth factor beta (TGF-beta) in endothelial cells.
  • To determine how specific phosphorylation sites on Cav-2 affect TGF-beta-induced cellular responses.

Main Methods:

  • Utilized Cav-2 knockout endothelial cells.
  • Re-expressed wild-type and mutant forms of Cav-2 (Y19/27F-Cav-2 and S23/36A-Cav-2) via retroviral vectors.
  • Assessed the anti-proliferative effects of TGF-beta.
  • Analyzed TGF-beta-induced Smad3 phosphorylation and plasminogen activator inhibitor-1 (PAI-1) transcriptional activation.

Main Results:

  • Tyrosine phosphorylation of Cav-2 negatively regulates the anti-proliferative effect of TGF-beta.
  • Re-expression of Y19/27F-Cav-2 (non-tyrosine-phosphorylatable mutant) in Cav-2 knockout cells abolished the effect on TGF-beta's anti-proliferative function.
  • Re-expression of S23/36A-Cav-2 (serine phosphorylation mutant) partially reduced TGF-beta's anti-proliferative effect.
  • Differential effects of Cav-2 phosphorylation mutants correlated with Smad3 phosphorylation and PAI-1 activation.

Conclusions:

  • Tyrosine-phosphorylated Cav-2 acts as a negative regulator of TGF-beta's anti-proliferative activity in endothelial cells.
  • Specific phosphorylation events on Cav-2 differentially modulate TGF-beta signaling pathways.
  • This study elucidates a novel mechanism by which Cav-2 phosphorylation influences endothelial cell behavior in response to TGF-beta.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...